Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idacorp (IDA) Cash & Equivalents (2016 - 2025)

Idacorp (IDA) has disclosed Cash & Equivalents for 17 consecutive years, with $333.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents changed N/A to $333.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $333.2 million, a N/A change, with the full-year FY2024 number at $368.9 million, up 12.65% from a year prior.
  • Cash & Equivalents was $333.2 million for Q3 2025 at Idacorp, down from $634.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $634.5 million in Q1 2025 to a low of $134.8 million in Q2 2023.
  • A 5-year average of $274.5 million and a median of $238.9 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 43.53% in 2021, then soared 84.39% in 2023.
  • Idacorp's Cash & Equivalents stood at $215.2 million in 2021, then dropped by 17.5% to $177.6 million in 2022, then skyrocketed by 84.39% to $327.4 million in 2023, then increased by 12.65% to $368.9 million in 2024, then fell by 9.67% to $333.2 million in 2025.
  • Per Business Quant, the three most recent readings for IDA's Cash & Equivalents are $333.2 million (Q3 2025), $634.5 million (Q1 2025), and $368.9 million (Q4 2024).